PIN31: THE COST-EFFECTIVENESS OF PEGINTERFERON ALFA-2A (40KD) (PEGASYS) PLUS RIBAVIRIN (COPEGUS) VS. INTERFERON ALFA-2B PLUS RIBAVIRIN FOR CHRONIC HEPATITIS C (CHC)

Value in Health ◽

10.1016/s1098-3015(10)64008-9 ◽

2003 ◽

Vol 6 (3) ◽

pp. 262-263

Author(s):

SD Sullivan ◽

J Green ◽

KK Patel ◽

A Craxi ◽

A Alberti ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Interferon Alfa ◽

Peginterferon Alfa ◽

Download Full-text

PGI5 THE COST-EFFECTIVENESS OF PEGINTERFERON ALFA-2B (I2KD) PLUS RIBAVIRIN VS. INTERFERON ALFA-2B PLUS RIBAVIRIN FOR CHRONIC HEPATITIS C (CHC) IN A DEVELOPING COUNTRY—BRAZIL

Value in Health ◽

10.1016/s1098-3015(10)67512-2 ◽

2005 ◽

Vol 8 (6) ◽

pp. A119-A120

Author(s):

MC Fonseca ◽

GTB Araujo

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Developing Country ◽

Chronic Hepatitis C ◽

Interferon Alfa ◽

Peginterferon Alfa ◽

Download Full-text

PIN12 THE COST-EFFECTIVENESS ANALYSIS OF PEGINTERFERON ALFA-2A AND RIBAVIRIN VERSUS INTERFERON ALFA-2B AND RIBAVIRIN IN CHRONIC HEPATITIS C IN POLAND

Value in Health ◽

10.1016/s1098-3015(10)61909-2 ◽

2003 ◽

Vol 6 (6) ◽

pp. 749-750

Author(s):

E Orlewska ◽

J Juszczyk

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Cost Effectiveness Analysis ◽

Interferon Alfa ◽

Effectiveness Analysis ◽

Peginterferon Alfa ◽

Download Full-text

1102 THE COST-EFFECTIVENESS OF TELAPREVIR (TVR) IN COMBINATION WITH PEGYLATED INTERFERON-ALFA AND RIBAVIRIN (PR) FOR THE TREATMENT OF GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS

Journal of Hepatology ◽

10.1016/s0168-8278(12)61114-3 ◽

2012 ◽

Vol 56 ◽

pp. S434 ◽

Author(s):

S. Curtis ◽

S. Cure ◽

S. Gavart ◽

L. Dearden ◽

J. Fleischmann ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Pegylated Interferon Alfa ◽

The Cost ◽

Chronic Hepatitis C Patients

Download Full-text

PIN19 A COMPARISON OF COST-EFFECTIVENESS OF PEGINTERFERON ALFA-2A (40KD) (PEGASYS) PLUS RIBAVIRIN (COPEGUS) VERSUS INTERFERON ALFA-2B PLUS RIBAVIRIN AS FIRST TREATMENT OF CHRONIC HEPATITIS C IN THE UK

Value in Health ◽

10.1016/s1098-3015(10)66036-6 ◽

2004 ◽

Vol 7 (6) ◽

pp. 763-764

Author(s):

GJ Lewis ◽

J Green ◽

K Patel ◽

Z Philips

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Interferon Alfa ◽

The Uk ◽

Peginterferon Alfa

Download Full-text

A systematic review of the cost–effectiveness of peginterferon alfa-2b in the treatment of chronic hepatitis C

Expert Review of Pharmacoeconomics & Outcomes Research ◽

10.1586/14737167.7.6.577 ◽

2007 ◽

Vol 7 (6) ◽

pp. 577-595 ◽

Author(s):

Jonathan Shepherd ◽

Jeremy Jones

Keyword(s):

Systematic Review ◽

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Peginterferon Alfa ◽

Download Full-text

PIN19 THE COST-EFFECTIVENESS ANALYSIS OF COMBINATION OF PEGINTERFERON ALFA-2A AND RIBAVIRIN VERSUS COMBINATION OF PEGINTERFERON ALFA-2B AND RIBAVIRIN IN CHRONIC HEPATITIS C IN POLAND

Value in Health ◽

10.1016/s1098-3015(10)62487-4 ◽

2004 ◽

Vol 7 (3) ◽

pp. 356

Author(s):

E Orlewska

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Peginterferon Alfa ◽

Download Full-text

PIN27 The Cost-Effectiveness of Telaprevir (TVR) in Combination With Pegylated Interferon-Alfa and Ribavirin (PR) for the Treatment of Genotype 1(G1) Chronic Hepatitis C Patients

Value in Health ◽

10.1016/j.jval.2012.03.1303 ◽

2012 ◽

Vol 15 (4) ◽

pp. A241-A242

Author(s):

S. Cure ◽

S. Curtis ◽

F. Bianic ◽

S. Gavart ◽

L. Dearden ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Pegylated Interferon Alfa ◽

The Cost ◽

Chronic Hepatitis C Patients

Download Full-text

PGI18 Treatment of Chronic Hepatitis C Patients with Peginterferon Alfa-2a or Peginterferon Alfa-2b: A Cost-Effectiveness Analysis for the Portuguese NHS Setting

Value in Health ◽

10.1016/j.jval.2011.08.889 ◽

2011 ◽

Vol 14 (7) ◽

pp. A394-A395

Author(s):

J. Areias ◽

T. Branco ◽

F. Calinas ◽

A. Carvalho ◽

G. Macedo ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Peginterferon Alfa ◽

Chronic Hepatitis C Patients

Download Full-text

The Cost-Effectiveness of Telaprevir Triple Therapy in Treatment of Naïve Chronic Hepatitis C Patients In Turkey

Value in Health ◽

10.1016/j.jval.2014.08.2477 ◽

2014 ◽

Vol 17 (7) ◽

pp. A670

Author(s):

O. Ozdemir

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Triple Therapy ◽

Chronic Hepatitis C ◽

The Cost ◽

Chronic Hepatitis C Patients

Download Full-text

Cost-effectiveness of interferon alfa 2b and ribavirin in the treatment of chronic hepatitis C

10.1002/hep.510310339 ◽

2000 ◽

Vol 31 (3) ◽

pp. 807-808 ◽

Author(s):

W. Ray Kim ◽

John J. Poterucha

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Interferon Alfa

Download Full-text